Canagen Pharmaceuticals (30 Ophthalmic Generic Drugs and CTD Dossiers) is Buildings and Property in Canada that focus on ophthalmic drugs business. They cover business area such as thirty generic prescription ophthalmic drug, their CTD Dossiers, Richmond, Canada.
-
Ophthalmic Drugs
-
Building 152
11782 River Rd
Richmond, British Columbia V6X 1Z7
Canada
Private
thirty generic prescription ophthalmic drugtheir CTD DossiersRichmondCanada
* We use standard office opening hours in near Canagen Pharmaceuticals (30 Ophthalmic Generic Drugs and CTD Dossiers)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Canagen Pharmaceuticals (30 Ophthalmic Generic Drugs And CTD Dossiers) is Buildings and Property business from Canada that founded in - ( years old in ), Canagen Pharmaceuticals (30 Ophthalmic Generic Drugs and CTD Dossiers) business is focusing on Ophthalmic Drugs.
Canagen Pharmaceuticals (30 Ophthalmic Generic Drugs and CTD Dossiers) headquarter office and corporate office address is located in Building 152 11782 River Rd Richmond, British Columbia V6X 1Z7 Canada.
Canagen Pharmaceuticals (30 Ophthalmic Generic Drugs and CTD Dossiers) was founded in Canada.
In , Canagen Pharmaceuticals (30 Ophthalmic Generic Drugs and CTD Dossiers) is currently focus on ophthalmic drugs sector.
Above is snippet of Google Trends for "ophthalmic drugs" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Canagen Pharmaceuticals (30 Ophthalmic Generic Drugs and CTD Dossiers), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
